|
FY2026
12 months to Feb 28, 2026
|
FY2025
12 months to Feb 28, 2025
|
FY2024
12 months to Feb 29, 2024
|
FY2023
12 months to Feb 28, 2023
|
FY2022
0 months to Mar 14, 2022
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Engineering, research and development | |||||
| Selling, general and administration | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest expense, net (including $1,064 and $545 to related parties, respectively) | |||||
| Interest expense, net (including $1,866 and $1,538 to related parties, respectively) | |||||
| Gain on debt settlement | |||||
| Change in fair value of derivative warrant liability | |||||
| Loss on debt extinguishment – related party | |||||
| Change in fair value of derivative liability | |||||
| Other income | |||||
| Net loss | |||||
| Basic loss per share (in Dollars per share) | |||||
| Diluted loss per share (in Dollars per share) | |||||
| Basic weighted-average shares outstanding (in Shares) | |||||
| Diluted weighted-average shares outstanding (in Shares) | |||||
Loading...